Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-07 Sale | 2025-11-07 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $20.22 | $4,044,000 | 7,581,482 (Direct) | View |
| 2025-10-15 Sale | 2025-10-17 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 851,383 | $16.99 | $14,467,502 | 2,060,077 (Direct) | View |
| 2025-10-09 Sale | 2025-10-14 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 125,667 | $16.29 | $2,047,336 | 3,228,452 (Direct) | View |
| 2025-10-06 Sale | 2025-10-08 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 665,159 | $16.21 | $10,781,813 | 17,621,520 (Direct) | View |
| 2025-09-19 Sale | 2025-09-23 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 1,711,000 | $14.92 | $25,524,777 | 21,596,902 (Direct) | View |
| 2025-09-18 Purchase | 2025-09-18 7:28 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 3,315 | $15.07 | $49,957 | 17,287,081 (Direct) | View |
| 2025-09-03 Sale | 2025-09-05 5:01 pm | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 1,775,749 | $12.65 | $22,456,210 | 48,866,216 (Indirect Direct) | View |
| 2025-08-20 Sale | 2025-08-22 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $11.72 | $1,172,000 | 9,692,482 (Direct) | View |
| 2025-07-21 Sale | 2025-07-23 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $11.52 | $1,152,000 | 9,601,120 (Direct) | View |
| 2025-06-20 Sale | 2025-06-24 9:01 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $11.45 | $1,145,000 | 9,701,120 (Direct) | View |
| 2025-06-18 Sale | 2025-06-23 11:35 am | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 1,142,273 | $11.46 | $13,084,796 | 50,641,965 (Indirect Direct) | View |
| 2025-06-04 Sale | 2025-06-06 5:49 pm | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 748,230 | $11.3 | $8,454,808 | 51,784,238 (Indirect Direct) | View |
| 2025-06-02 Sale | 2025-06-04 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 1,000,000 | $11.15 | $11,154,942 | 18,925,043 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-07 Exercise | 2025-11-07 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $20.22 | 7,581,482 (Direct) | View |
| 2025-11-07 Exercise | 2025-11-07 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 7,581,482 (Direct) | View |
| 2025-10-20 Option Award | 2025-10-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,056 | $0 | 56,904 (Direct) | View |
| 2025-10-20 Tax Withholding | 2025-10-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 158 | $17.74 | 108,543 (Direct) | View |
| 2025-10-20 Option Award | 2025-10-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 789 | $0 | 108,543 (Direct) | View |
| 2025-10-20 Tax Withholding | 2025-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 281 | $17.74 | 118,388 (Direct) | View |
| 2025-10-20 Option Award | 2025-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 1,507 | $0 | 118,388 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 851,383 | $0 | 2,060,077 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 851,383 | $15.85 | 2,060,077 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-14 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 125,667 | $0 | 3,228,452 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-14 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 125,667 | $15.85 | 3,228,452 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 260,326 | $7.45 | 17,621,520 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 665,159 | $0 | 17,621,520 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 17,621,520 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 204,833 | $15.85 | 17,621,520 (Direct) | View |
| 2025-09-28 Tax Withholding | 2025-09-30 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,341 | $15.17 | 389,508 (Direct) | View |
| 2025-09-20 Tax Withholding | 2025-09-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,129 | $15.04 | 391,849 (Direct) | View |
| 2025-09-19 Exercise | 2025-09-23 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 1,562,374 | $0 | 21,596,902 (Direct) | View |
| 2025-09-19 Exercise | 2025-09-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 1,562,374 | $3.85 | 21,596,902 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 48,250 | $0 | 1,982,129 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 5,270 | $13.77 | 9,004,890 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 48,250 | $0 | 9,004,890 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 937 | $13.77 | 77,626 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 48,250 | $0 | 77,626 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 2,043 | $13.77 | 152,931 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 48,250 | $0 | 152,931 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 3,282 | $13.77 | 144,920 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 48,250 | $0 | 144,920 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,661 | $13.77 | 91,235 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 48,250 | $0 | 91,235 (Direct) | View |
| 2025-08-28 Tax Withholding | 2025-09-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,340 | $11.94 | 393,978 (Direct) | View |
| 2025-08-20 Tax Withholding | 2025-08-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,235 | $11.72 | 396,318 (Direct) | View |
| 2025-08-20 Exercise | 2025-08-22 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $0 | 9,692,482 (Direct) | View |
| 2025-08-20 Tax Withholding | 2025-08-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 7,051 | $11.72 | 9,692,482 (Direct) | View |
| 2025-08-20 Exercise | 2025-08-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $3.85 | 9,692,482 (Direct) | View |
| 2025-07-30 Option Award | 2025-08-01 9:12 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 13,736,547 | $0 | 13,736,547 (Direct) | View |
| 2025-07-30 Option Award | 2025-08-01 9:09 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 198,413 | $0 | 1,660,636 (Direct) | View |
| 2025-07-28 Tax Withholding | 2025-07-30 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,919 | $11.35 | 397,553 (Direct) | View |
Ownership | 2025-07-29 9:00 pm | N/A 2028-09-19 | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 0 | $0 | 10,271,639 (Direct) | View |
| 2025-07-21 Exercise | 2025-07-23 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $0 | 9,601,120 (Direct) | View |
| 2025-07-21 Exercise | 2025-07-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $3.85 | 9,601,120 (Direct) | View |
| 2025-04-17 Option Award | 2025-07-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 2,296 | $0 | 104,681 (Direct) | View |
| 2025-04-17 Tax Withholding | 2025-07-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 115 | $11.65 | 104,681 (Direct) | View |
| 2025-07-17 Option Award | 2025-07-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 1,201 | $0 | 96,670 (Direct) | View |
| 2025-07-17 Tax Withholding | 2025-07-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 241 | $11.65 | 96,670 (Direct) | View |
| 2025-07-17 Option Award | 2025-07-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,609 | $0 | 42,985 (Direct) | View |
| 2025-06-28 Tax Withholding | 2025-07-01 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,653 | $11.39 | 399,472 (Direct) | View |
| 2025-06-25 Other | 2025-06-27 5:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 36,756,758 | $0 | 66,987,034 (Indirect) | View |
| 2025-06-25 Other | 2025-06-27 5:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 17,389,525 | $0 | 20,915,884 (Indirect) | View |
| 2025-06-25 Other | 2025-06-27 5:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director | 36,756,758 | $0 | 38,349,238 (Indirect) | View |
| 2025-06-20 Tax Withholding | 2025-06-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,503 | $11.45 | 399,056 (Direct) | View |
| 2025-06-20 Exercise | 2025-06-24 9:01 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $0 | 9,701,120 (Direct) | View |
| 2025-06-20 Exercise | 2025-06-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $3.85 | 9,701,120 (Direct) | View |
| 2025-06-02 Exercise | 2025-06-04 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 1,385,026 | $0 | 18,925,043 (Direct) | View |
| 2025-06-02 Exercise | 2025-06-04 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 1,385,026 | $3.85 | 18,925,043 (Direct) | View |
| 2025-05-28 Tax Withholding | 2025-05-30 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,653 | $10.62 | 400,559 (Direct) | View |
| 2025-05-20 Tax Withholding | 2025-05-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 3,487 | $11.04 | 402,212 (Direct) | View |